drugset / Trial / NCT07042581

A Study of Revaree Plus in People With Breast Cancer

NCT07042581

Phase 4 Recruiting 60 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.

Timeline

Start
2025-06-20
Primary completion
2029-06-20
Completion
2029-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified Other